Meta Pixel

Company Updates

Company Updates
Novogen Encouraged by FDA for Phase II Study

Following the successful completion of phase I of GDC-0084 in a clinical trial in advanced glioma, Novogen is set to take this into phase II clinical trial in the treatment of glioblastoma multiforme.

Join over 45,000+ sophisticated investors

Join Now